AXIM BIOTECHNOLOGIES, INC. (AXIM)
About AXIM BIOTECHNOLOGIES, INC.
AXIM BIOTECHNOLOGIES INC
This profile is unclaimed. An authorized representative can claim it to add details and earn the Verified badge.
Financial summary
- Revenue FY2023
- $39.5K
- Net income
- -$8.1M
- Total assets
- $4.1M
Source: SEC EDGAR · updated Jun 8, 2026
15-minute delayed · data by Polygon.io
Past year · hover for prices
52-week range
- Open
- —
- Day range
- –
- Prev close
- —
- Volume
- —
Axim Biotechnologies, Inc. (AXIM) Stock Price
- Reported a net loss of $8.1M in FY2023.
Automatically generated from public filings and market data. Informational only — not investment advice or a recommendation to buy or sell any security.
No reviews yet. Be the first to review AXIM BIOTECHNOLOGIES, INC..
Write a review
Axim Biotechnologies, Inc.: frequently asked questions
Is Axim Biotechnologies, Inc. an American company?
Axim Biotechnologies, Inc. is a US-based company headquartered in San Diego, California, listed in the americancompanies.com directory of American companies. Its American-origin credentials have not yet been independently verified.
Where is Axim Biotechnologies, Inc. headquartered?
Axim Biotechnologies, Inc. is headquartered in San Diego, California, United States.
Is Axim Biotechnologies, Inc. publicly traded?
Yes — Axim Biotechnologies, Inc. is a publicly traded company. Its stock trades under the ticker symbol AXIM on the OTC.
What does Axim Biotechnologies, Inc. do?
Axim Biotechnologies, Inc. is an American Pharmaceuticals company in the Health & Beauty sector.
